Wartrin Wart Remover

Description

WARTRIN is a pharmaceutical agent indicated for the treatment of specific medical conditions. The active ingredient is characterized by its unique chemical structure, which contributes to its therapeutic efficacy. The molecular weight and chemical formula are essential for understanding its pharmacokinetics and pharmacodynamics. WARTRIN is formulated in a dosage form suitable for administration, ensuring optimal absorption and bioavailability. The product is presented in a specific appearance that meets regulatory standards for quality and consistency. Inactive ingredients included in the formulation serve to stabilize the active component and enhance the overall effectiveness of the medication.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by a rough, 'cauliflower-like' appearance on the surface. Additionally, it is indicated for the removal of plantar warts, which are located exclusively on the bottom of the foot and are identified by tenderness and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the wart may be soaked in warm water for approximately 5 minutes. After soaking, the area must be dried completely.

A "one drop" or "small amount" of the medication should be applied at a time using an applicator or brush, ensuring that each wart is sufficiently covered. It is important to allow the application to dry completely.

This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on irritated skin, infected or reddened areas, in patients with diabetes, or in individuals with poor blood circulation due to the potential for exacerbating these conditions.

• Application on moles, birthmarks, warts with hair, genital warts, or warts located on the face or mucous membranes, as these may pose additional risks.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame.

The product should not be applied to irritated skin, infected or reddened areas, or on individuals with diabetes or poor blood circulation. It is contraindicated for use on moles, birthmarks, warts with hair, genital warts, or warts located on the face or mucous membranes.

When using this product, if discomfort persists, it is advised to consult a healthcare professional. In the event that the product comes into contact with the eyes, it is crucial to flush the eyes with water for at least 15 minutes. Users should also avoid inhaling vapors to minimize respiratory irritation.

This product must be kept out of reach of children. If ingested, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

For individuals who are pregnant or breastfeeding, it is recommended to consult a healthcare professional prior to use to ensure safety.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should be kept away from fire or flame due to its flammable nature. It is contraindicated for use on irritated skin, infected or reddened areas, and should not be applied if the patient is diabetic or has poor blood circulation. Additionally, the product should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

During the use of this product, if discomfort persists, patients are advised to consult their doctor. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

It is crucial to keep this product out of reach of children. If swallowed, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional prior to use to ensure safety.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Wartrin Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been specified. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to irritated skin, infected areas, or on individuals with diabetes or poor blood circulation. Additionally, patients should be cautioned against using the product on moles, birthmarks, warts with hair, genital warts, or warts located on the face or mucous membranes.

Patients should be instructed to consult their doctor if discomfort persists after using the product. In the event that the product comes into contact with the eyes, patients should be advised to flush the eyes with water for at least 15 minutes. Furthermore, healthcare providers should emphasize the importance of avoiding inhalation of vapors associated with the product.

Storage and Handling

The product is supplied in a container designed to safeguard its integrity. It is essential to protect the product from excessive heat and direct sunlight to maintain its efficacy and safety. Proper storage conditions should be observed to ensure optimal performance.

Additional Clinical Information

The product is administered topically, with patients instructed to apply "one drop" or a "small amount" at a time using an applicator or brush to adequately cover each wart. This application should be allowed to dry, and the procedure may be repeated once or twice daily as needed, up to a maximum of 12 weeks, until the wart is removed.

Clinicians should counsel patients on several important safety measures. If discomfort persists, patients are advised to consult their doctor. In the event of contact with the eyes, the area should be flushed with water for 15 minutes. Patients should avoid inhaling vapors and seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Additionally, pregnant or breastfeeding patients should consult a healthcare professional before use.

Drug Information (PDF)

This file contains official product information for Wartrin Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)